Glycorex Transplantation

1.22 SEK

+0.83%

Less than 1K followers

GTAB B

NGM Main Regulated

Biotechnology & Pharmaceuticals

Health Care

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Glycorex Transplantation

2019202020212022202320242025
Revenue36.127.028.236.130.035.238.8
growth-%-25.2 %4.5 %28.1 %-17.1 %17.4 %10.5 %
EBITDA12.60.1-3.30.3-8.9-1.12.0
EBIT7.5-7.7-11.8-8.3-30.3-10.4-7.3
Profit before taxes6.9-8.1-12.2-8.5-30.4-11.0-7.8
Net income6.9-8.0-12.2-8.6-30.4-10.9-7.7
EPS0.10-0.11-0.17-0.12-0.41-0.15-0.10
Dividend0.000.000.000.000.000.000.00
Dividend ratio0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%34.9 %0.4 %-11.9 %0.7 %-29.8 %-3.2 %5.1 %
EBIT-%20.8 %-28.6 %-42.0 %-23.0 %-101.1 %-29.7 %-18.9 %
ROE10.9 %-8.4 %-14.8 %-11.5 %-68.9 %-33.0 %-22.4 %
ROI8.0 %-7.1 %-12.0 %-8.9 %-46.1 %-21.7 %-15.2 %